Progressive increase of inflammatory biomarkers in chronic kidney disease and end-stage renal disease

Clinical and Applied Thrombosis/Hemostasis

Volumn 19, Issue 3, 2013, Pages 303-308

  Sharain, Korosh ^a   Hoppensteadt, Debra ^a   Bansal, Vinod ^a   Singh, Ajay ^b   Fareed, Jawed ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

atherosclerosis; blood coagulation factors; cardiology; hypercoagulability; nephrology; renal failure

Indexed keywords

C REACTIVE PROTEIN; D DIMER; NEURON SPECIFIC ENOLASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; THROMBOMODULIN; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; ARTICLE; BIOCHIP; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; HUMAN; KIDNEY FAILURE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UPREGULATION;

ATHEROSCLEROSIS; BLOOD COAGULATION FACTORS; CARDIOLOGY; HYPERCOAGULABILITY; NEPHROLOGY; RENAL FAILURE;

ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; LIPOCALINS; PHOSPHOPYRUVATE HYDRATASE; PROTO-ONCOGENE PROTEINS; RENAL INSUFFICIENCY, CHRONIC; THROMBOMODULIN;

EID: 84878870472     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029612454935     Document Type: Article

References (29)

1. National Kidney Foundation. The Facts About Chronic Kidney Disease (CKD). http://www.kidney.org/. Accessed July 12, 2011.
2. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002 ; 39 (2 suppl 1). S1 - S266
3. National Kidney & Urologic Diseases Information Clearinghouse (NKUDIC). http://kidney.niddk.nih.gov. Accessed July 15, 2011.
4. Tveit DP, Hypolite IO, Hshieh P, et al. Chronic dialysis patients have high risk for pulmonary embolism. Am J Kidney Dis. 2002 ; 39 (5). 1011-1017
5. Casserly LF, Dember LM. Thrombosis in end-stage renal disease. Semin Dial. 2003 ; 16 (3). 245-256
6. Cheung FK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000 ; 58 (1). 353-362
7. Hruska K, Mathew S, Lund R, Fang Y, Sugatani T. Cardiovascular risk factors in chronic kidney disease: does phosphate qualify?. Kidney Int Suppl. 2011 ; (121). S9 - S13
8. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis. 2000 ; 35 (4 suppl 1). S117 - S131
9. Collins AJ. Cardiovascular mortality in end-stage renal disease. Am J Med Sci. 2003 ; 325 (4). 163-167
10. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998 ; 32 (5 suppl 3). S112 - S119
11. Zager PG, Nikolic J, Brown RH, et al. "U" curve association of blood pressure and mortality in hemodialysis patients. Kidney Int. 1998 ; 54 (2). 561-569
12. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 1990 ; 15 (5). 458-482
13. Bolignano D, Lacquanti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009 ; 4 (2). 337-344
14. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004 ; 351 (13). 1296-1305
15. Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, Hoy WE. Biomarkers in chronic kidney disease: a review. Kidney Int. 2011 ; 80 (8). 806-821
16. Wang AY, Lai K. Use of cardiac biomarkers in end-stage renal disease. J Am Soc Nephrol. 2008 ; 19 (9). 1643-1652
17. Devarajan P. The use of targeted biomarkers for chronic kidney disease. Adv Chronic Kidney Dis. 2010 ; 17 (6). 469-479
18. Nelson K, Thethi I, Cunanan J, et al. Upregulation of surrogate markers of inflammation and thrombogenesis in patients with ESRD: pathophysiological and therapeutic implications. Clin Appl Thromb Hemost. 2011 ; 17 (3). 302-304
19. Adams MJ, Irish AB, Watts GF, Oostryck R, Dogra GK. Hypercoagulability in chronic kidney disease is associated with coagulation activation but not endothelial function. Thromb Res. 2008 ; 123 (2). 374-380
20. Shlipak MG, Fried LF, Crump C, et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003 ; 107 (1). 87-92
21. Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2000 ; 35 (3). 469-476
22. Knight EL, Rimm EB, Pai JK, et al. Kidney dysfunction, inflammation, and coronary events: a prospective study. J Am Soc Nephrol. 2004 ; 15 (7). 1897-1903
23. Constantin JM, Futier E, Perbet S, et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker of acute kidney injury in adult critically ill patients: a prospective study. J Crit Care. 2010 ; 25 176 (1). e1 - e6
24. Malyszko J, Malyszko JS, Bachorzewska-Gajewska H, Poniatowski B, Dobrzycki S, Mysliwiec M. Neutrophil gelatinase-associated lipocalin is a new and sensitive markers of kidney function in chronic kidney disease patients and renal allograft recipients. Transplant Proc. 2009 ; 41 (1). 158-161
25. Hemdahl AL, Gabrielsen A, Zhu C, et al. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol. 2006 ; 26 (1). 136-142
26. Bolignano D, Basile G, Parisi P, Coppolino G, Nicocia G, Buemi M. Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure. Rejuvenation Res. 2009 ; 12 (1). 7-14
27. Khatri M, Wright CB, Nickolas TL, et al. Chronic kidney disease is associated with white matter hyperintensity volume. Stroke. 2007 ; 38 (12). 3121-3126
28. Anand N, Stead LG. Nueron-specific enolase as a marker for acute ischemic stroke: a systematic review. Cerebrovas Dis. 2005 ; 20 (4). 213-219
29. Peralta CA, Shlipak MG, Judd S, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin to creatinine ration and association with progression to end-stage renal disease and mortality. JAMA. 2011 ; 305 (15). 1545-1552